Libidon®
in points from 1 to 5 (1 - the norm, 5 - the most significant changes in the indicator).
A palpation assessment of the prostate gland, a laboratory study of its secretion, and a more in-
depth analysis of the state of copulatory function were performed along with the studies mentioned
above. Ultrasound examination of the prostate was conducted using a portable ultrasound machine
(SHIMADZU, Japan).
RESEARCH RESULTS
When evaluating the treatment results with LIBIDON® for chronic prostatitis, the primary attention
was paid to clinical criteria. At the end of treatment, the pain completely disappeared in 64.0%
and significantly decreased in 32.7% of patients presenting corresponding complaints. In 3.3%
of patients, the treatment did not give the expected effect, and the dynamics of pain were not
observed.
Of the number of patients suffering from sexual dysfunction, 44.4% indicated their complete
recovery, and 41.8% noted an improvement. The positive effect of the drug was manifested in
improving the quality of erection, enhancing orgasms, and eliminating their pain. An increase in the
duration of intercourse was also noted. By the end of treatment, 37.1% of patients reported libido
recovery.
Pollakiuria (increased frequency of urination) altogether ceased to bother 87.5% of patients. The
need to urinate at night has disappeared.
Stranguria (difficulty urinating) ceased to bother 80.7% of patients, 15.9% noted an increase in the
urine stream and relief of the act of urination.
Summary information on the change in the act of urination in patients with chronic prostatitis after
treatment with LIBIDON® is presented in Table 2.
Palpation of the prostate gland through the rectum revealed a tendency to restore its size and
consistency after complex treatment with LIBIDON®. At the same time, areas of compaction
disappeared, and the study itself became painless. The observed decrease in the prostate gland
size, regarded as a result of a decrease in the edema of the interstitial tissue and indicating the
elimination of the activity of the inflammatory process in it, was also confirmed by the results of
ultrasound diagnostics.
Thanks to the restoration of the function of the prostate gland under the influence of LIBIDON®,
an improvement in the properties of its secretion was observed. This provided an increase in the
content of motile spermatozoa in the ejaculation by 11.8%. Decreased leukocytes confirmed a
decrease in the inflammatory process activity in the ejaculation, prostate secretions, and urine. At
the same time, a reduction in the content of cells of desquamated epithelium in the test material
was observed.
The dynamics of the study results in patients with prostate adenoma before and after the course of
treatment with LIBIDON® is presented in Table 3.
The influence of LIBIDON® on the state of urodynamics in patients Table 2
with chronic prostatitis
Indicator Before After Treatment with After Treatment with
Treatment Conventional Methods Libidon®
Average urination rate, (ml/sec) 17,3±1,2 19,8±1,6 23,5±2,4*
Maximum speed of 22,1±2,3 24,4±2,1 26,5±3,1
urination, (ml/sec)
Time to reach the maximum 3,6±0,2 2,8±0,1 1,5±0,1*
urination rate, (ml/sec)
* p <0.05 - significant compared with the indicator before treatment.
Для таблиц, дозировок и примечаний сверяйтесь с оригинальным PDF: при извлечении текста порядок колонок может измениться.
Из библиотеки Peptides. Авторство и содержание оригинала сохранены. Размещено с разрешения поставщика.